No ASX ETF holds Avita Medical (AVH) as of 15 Oct 2026. Over the last 3 months it rose 223.5%: on $10,000, +$22348. We explain 5 big moves in that time.
About AVH
- SectorHealth Care
- IndustryPharmaceuticals, Biotechnology & Life Sciences
- Size$588.3m
- Held by0 ETFs
- Big moves5 in 3M
Each dot is a move we explain. Tap one, or a row of Why it moved, to see what caused it.
Why it moved
- +8.1%peak +8.8%25 Sep 2026· No Catalyst Found
No identifiable catalyst was found; the stock rose sharply against a falling market and weak sector peers with no announcements, news, or related signals to explain the move.
- +4.1%peak +5.5%20 Aug 2026· Unknown
The stock rose sharply without any company announcement, likely driven by an undisclosed catalyst such as a takeover bid, major contract, or news not yet captured in available sources.
- +31.8%10 Aug 2026· Operational
Avita Medical announced an investor webinar featuring its Q2 earnings overview, prompting investor optimism and a surge in the stock price.
- +20.3%7 Aug 2026· Unknown
No clear catalyst has been identified; the sharp price rise appears to be driven by an unknown event such as an unannounced deal, takeover speculation, or information not yet captured in public sources.
- +16.1%peak +18.3%16 Jul 2026· Unknown
No clear catalyst is identifiable; the sharp 16.5% rise appears to lack a confirmed trigger, as there are no company announcements, the sector move is negligible, and recent news only references a prior price drop
Held by 0 ETFs
No ETF we track holds AVH directly.
Other Health Care companies
- SHLSonic Healthcare47 ETFs
- RMDResMed44 ETFs
- CSLCSL Limited42 ETFs
- BDXBcal36 ETFs
- CSXCleanspace36 ETFs
- REGRegis Health33 ETFs
- TLXTelix Pharma32 ETFs
- SIGSigma Healthcare31 ETFs
Why did AVH rise 31.8% on 10 Aug 2026?
Avita Medical
Avita Medical announced an investor webinar featuring its Q2 earnings overview, prompting investor optimism and a surge in the stock price.
An investor webinar featuring a Q2 earnings overview was announced on the same day as the price surge, providing a direct company-specific catalyst. The news also suggests the stock was already being discussed favorably by analysts, potentially setting up positive sentiment heading into the event. While not an explicit earnings beat, the market is likely reacting to the upcoming earnings and any potential positive updates it might include.
Written by a language model from the evidence below, and it can be wrong. Tell us and we will fix or remove it. General information only, not financial product advice. It does not consider your objectives, finances or needs. Past performance is not a guide to future performance.
Evidence
News coverage